Floatz logo

ALLOGENEIC HUMAN UMBILICAL CORD BLOOD

Severe Aplastic Anemia

West Virginia UniversityCell therapyN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Severe Aplastic Anemia cohort.

Asset / SponsorPhaseRating
Evomela
Masonic Cancer Center, University of Minnesota
Phase 2BB
Fludarabine
Masonic Cancer Center, University of Minnesota
Phase 2BB
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 2B
Fludarabine
Masonic Cancer Center, University of Minnesota
Phase 2B
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2B

View all 26 →

Same molecule, other indications

ALLOGENEIC HUMAN UMBILICAL CORD BLOOD is also rated in:

acute lymphoblastic leukemiaDormant
B
Indicative ·
61 / 100
View asset →
acute myeloid leukemiaDormant
B
Indicative ·
59 / 100
View asset →
myelodysplastic syndromeDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →